Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.

Endometriosis: Current Therapies and New Pharmacological Developments

Abstract

Endometriosis is a chronic inflammatory condition that is responsive to management with steroids. The establishment of a steady hormonal environment and inhibition of ovulation can temporarily suppress ectopic implants and reduce inflammation as well as associated pain symptoms. In terms of pharmacological management, the currently available agents are not curative, and treatment often needs to be continued for years or until pregnancy is desired. Similar efficacy has been observed from the various therapies that have been investigated for endometriosis. Accordingly, combined oral contraceptives and progestins, based on their favourable safety profile, tolerability and cost, should be considered as first-line options, as an alternative to surgery and for post-operative adjuvant use. In situations where progestins and oral contraceptives prove ineffective, are poorly tolerated or are contraindicated, gonadotrophin-releasing hormone analogues, danazol or gestrinone may be used. Future therapeutic options for managing endometriosis must compare favourably against existing agents before they can be considered for inclusion into current practice. Finally, as reproductive prognosis is not ameliorated by medical treatment, it is not indicated for women seeking conception.

Overview

Integrity signals

Registry

Crossref · 10.2165/00003495-200969060-00002

Cites

175 of 175 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 175 references

Research works printed but not linked: 21

  1. 2006, Fertil Steril, 86, S156
  2. Muneyyirci-Delale, 1998, Int J Fertil Womens Med, 43, 24
  3. Moore, 1999, Drugs Today, 35, 41
  4. Fedele, 1989, Obstet Gynecol, 73, 1000
  5. Moran, 1996, Arch Med Res, 27, 535
  6. Bergqvist, 2001, Acta Obstet Gynecol Scand, 80, 628, 10.1080/j.1600-0412.2001.800708.x · DOI
  7. Reimnitz, 1988, Obstet Gynecol, 71, 444
  8. Lavery, 2001, BJOG, 108, 1106
  9. Gücer, 1998, Eur J Gynaecol Oncol, 19, 39
  10. Oxholm, 2007, Acta Obstet Gynecol Scand, 4, 1
  11. Davis, 2007, Cochrane Database Syst Rev, 3, CD001019
  12. Prentice, 2007, Cochrane Database Syst Rev, 3, CD000346
  13. Surrey, 2002, Obstet Gynecol, 99, 709
  14. Yap, 2004, Cochrane Database Syst Rev, 3, CD003678
  15. Sallam, 2006, Cochrane Database Syst Rev, 1, CD004635
  16. Rotondi, 2002, Eur J Gynaecol Oncol, 23, 523
  17. Selak, 2001, Cochrane Database Syst Rev, 4, CD000068
  18. Viganò, 2003 Oct, Curr Opin Investig Drugs, 4, 1209
  19. Holcombe, 2001, Cancer Detect Prev, 25, 183
  20. Badawy, 2001, Obstet Gynecol, 98, 417
  21. Lev-Ari, 2008 Jan, Recent Pat Anticancer Drug Discov, 3, 55

Cited by

See all 182

Metadata

Authors
Vercellini, P., Somigliana, E., Viganò, P., Abbiati, A., Barbara, G., & Crosignani, P. G.
Affiliations
  • University of Milan (IT)
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
  • IRCCS Ospedale San Raffaele (IT)
Corresponding author
Vercellini, Paolo
Venue
Drugs
Published
2009
Volume
69
Issue
6
Pages
649-675
ISSN
0012-6667 (ISSN-L)
OpenAlex
W2077356215
Cited by
182
References
175
Citations by year
2026: 8 · 2025: 6 · 2024: 7 · 2023: 20 · 2022: 2 · 2021: 6 · 2020: 8 · 2019: 8 · 2018: 8 · 2017: 8 · 2016: 6 · 2015: 12 · 2014: 14 · 2013: 7 · 2012: 13
FWCI
2.82
Type
journal article
Language
en
Open access
closed
Locations
  • Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
endometriosis, medical management, combined oral contraceptives, progestins, GnRH analogues, danazol, gestrinone, ovulation inhibition, hormonal suppression, chronic inflammation, fertility preservation
MeSH terms
Clinical Trials as Topic, Danazol, Drug Therapy, Endometriosis, Estrogens, Female, Gestrinone, Humans, Gonadotropin-Releasing Hormone, Progestins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endometriosis: Current Therapies and New Pharmacological Developments. https://app.cochat.ai/papers/10.2165/00003495-200969060-00002
The paper
Vercellini, P., Somigliana, E., Viganò, P., Abbiati, A., Barbara, G., & Crosignani, P. G. (2009). Endometriosis: Current Therapies and New Pharmacological Developments. Drugs. https://doi.org/10.2165/00003495-200969060-00002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.